Evidence map›Paper›PMID 30003713›Full record

ArticleThe journal of pathology. Clinical research2018

You won't believe this old test … that does cheap single-cell mutation detection.

Martin Köbel, Michael S Anglesio, James D Brenton

Abstract readComment
In one paragraph

Article in The journal of pathology. Clinical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Iatrogenic endometriosis harbors somatic cancer-driver mutations.Human reproduction (Oxford, England) · 2019
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Martin KöbelDepartment of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Centre, Calgary, Alberta, Canada.ORCID 0000-0002-6615-2037
Michael S AnglesioDepartment of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0003-1639-5003
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

Funding

Cancer Research UK 15601Cancer Research UK 22905
6 · The paper itself

Abstract

Detecting mutations in single cells from cancer specimens is now a major area of translational research. In a recent article in this journal, Khalique et al validated an immunohistochemistry assay for ARID1A that reliably identifies loss of function mutations in single cells in tissue sections. This work exemplifies best practice for developing and orthogonally validating immunohistochemical assays to provide clearly interpretable mutational results with spatial context.

Indexed as

Genital Neoplasms, FemaleDNA-Binding ProteinsFemaleHumansImmunohistochemistryMutationNuclear ProteinsTranscription FactorsARID1A protein, humanDNA-Binding ProteinsNuclear ProteinsTranscription FactorsFemale reproductive systemImmunohistochemistryMutationOvaryTesting

Identifiers

PMID30003713
PMCPMC6065114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.